This project will help the firm develop, optimize and characterize a formulation of their lead therapeutic compound that is suitable for administration via subcutaneous injection. Efficacy of the new...
Mesentech Inc.
4 records totalling $763,500.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $763,500 | 4 records |
Records
This project will help the firm qualify a non-rodent species for future IND-enabling safety studies by supporting the development of species-specific analytical methods as well as methods required for...
This project will support the firm to develop analytical methods and obtain initial toxicology information for their lead compound that will be used to support future IND-enabling studies.
To support upcoming IND filings the firm’s lead candidate bone growth promoting drug will be tested for efficacy in animal (rodent) models, one requiring systemic administration and the other requirin...